Sipai Network

Founded in 2014, Sipai Company is an innovative company specializing in the development of multicenter databases in the medical field (oncology and special treatments), big data management and mining, and providing intelligent medical solutions. It has already received a Series B investment of tens of millions of US dollars from foreign investment companies.
Sipai's database adopts internationally advanced medical and management models combined with China's unique medical characteristics. It features customized data formats, standardized fields, professional rigor, multicenter networking, and effective protection of data security and patient privacy. It also provides comprehensive services such as data entry, processing and analysis, and patient follow-up, creating a patient management and big data processing system that is usable and easy for doctors.
Since its establishment, the company has grown rapidly. It has collaborated with many domestic experts and departments, successfully developed and operated professional disease databases in oncology and special treatment fields nationwide, and established strategic cooperation with many well-known domestic pharmaceutical companies. Cooperative associations or units include the China Prostate Cancer Alliance, the China Bladder Cancer Alliance, the China Alliance for Minimally Invasive Tumor Therapy (registered with the Ministry of Science and Technology), and the National Clinical Research Center for Digestive Diseases. Diseases covered include breast cancer, lung cancer, sarcoma, liver cancer, pancreatic cancer, colorectal cancer, esophageal cancer, GIST, gastric cancer, prostate cancer, bladder cancer, renal cancer, ovarian cancer, endometrial cancer, cervical cancer, lymphoma, myeloma, multiple sclerosis, pulmonary hypertension, and others.